hospital covid-19 patient

COVID-19 data scandal prompts tweaks to elite journal’s review process

Reading now: 642
www.sciencemag.org

Kelly ServickScience’s COVID-19 reporting is supported by the Pulitzer Center and the Heising-Simons Foundation.Three months after retracting a high-profile COVID-19 paper, editors at The Lancet hope to assure the research community that they’ve learned their lesson.

The journal yanked a study on risks of hydroxychloroquine—an antimalarial drug whose proposed use as a COVID-19 treatment has stirred scientific and political controversy—in June when its authors couldn’t prove the underlying patient data even existed.

Yesterday, it announced policies, effective immediately, that aim to keep flawed studies using “large, real-word datasets” from slipping past peer review again.

Read more on sciencemag.org
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA